A Study to Evaluate the Efficacy and Safety of Hemay005 in the Treatment of Behçet Disease
Clinical trial NCT04609397 · TERMINATED
Trial details
- NCT number
- NCT04609397
- Sponsor
- Tianjin Hemay Pharmaceutical Co., Ltd
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-30
- Primary completion
- 2022-04-30
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.